- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Winter Olympics
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: A rant about medical practices and pharmaceuticals
Posted on 1/20/24 at 6:34 am to Knuckle Checker
Posted on 1/20/24 at 6:34 am to Knuckle Checker
quote:
It didn’t disrupt white matter in her brain you fricking psycho.
quote:
Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross-sectional study using data from the UK Biobank
quote:
This study extends these findings by investigating brain volumes and white matter microstructure in not only systemic glucocorticoid users, but also inhaled glucocorticoid users, in whom neuropsychiatric side effects have been reported too.62 The most remarkable and consistent associations were observed in white matter integrity, as both systemic and inhaled glucocorticoid use was associated with widespread reductions in FA and increases in MD.
LINK
0
Posted on 1/20/24 at 8:06 am to StringedInstruments
I work with mentally ill kids. I have seen similar issues with Flovent. If asthma is the problem, you might consider seeing a specialist. In my experience, they are more likely to change meds when negative side effects occur.
Posted on 1/20/24 at 9:04 am to Pezzo
Black box warning on Singulair fyi:
Montelukast
ALERT: US Boxed Warning
?Serious neuropsychiatric events:
Serious neuropsychiatric (NP) events have been reported with the use of montelukast. The types of events reported were highly variable, and included, but were not limited to, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide). The mechanisms underlying NP events associated with montelukast use are currently not well understood.
Because of the risk of NP events, the benefits of montelukast may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with alternative therapies. Reserve use of montelukast for patients with allergic rhinitis who have an inadequate response or intolerance to alternative therapies. In patients with asthma or exercise-induced bronchoconstriction, consider the benefits and risks before prescribing montelukast.
Discuss the benefits and risks of montelukast with patients and caregivers when prescribing montelukast. Advise patients and/or caregivers to be alert for changes in behavior or new NP symptoms when taking montelukast. If changes in behavior are observed, or if new NP symptoms or suicidal thoughts and/or behavior occur, advise patients to discontinue montelukast and contact a health care provider immediately
Montelukast
ALERT: US Boxed Warning
?Serious neuropsychiatric events:
Serious neuropsychiatric (NP) events have been reported with the use of montelukast. The types of events reported were highly variable, and included, but were not limited to, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide). The mechanisms underlying NP events associated with montelukast use are currently not well understood.
Because of the risk of NP events, the benefits of montelukast may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with alternative therapies. Reserve use of montelukast for patients with allergic rhinitis who have an inadequate response or intolerance to alternative therapies. In patients with asthma or exercise-induced bronchoconstriction, consider the benefits and risks before prescribing montelukast.
Discuss the benefits and risks of montelukast with patients and caregivers when prescribing montelukast. Advise patients and/or caregivers to be alert for changes in behavior or new NP symptoms when taking montelukast. If changes in behavior are observed, or if new NP symptoms or suicidal thoughts and/or behavior occur, advise patients to discontinue montelukast and contact a health care provider immediately
Posted on 1/20/24 at 9:08 am to StringedInstruments
Asthma medications are often steroids that are known to excite children
Any doctor or nurse that doesn’t immediately inform you of this after these symptoms is legitimately retarded
Any doctor or nurse that doesn’t immediately inform you of this after these symptoms is legitimately retarded
Page 4 of 4
Popular
Back to top
Follow TigerDroppings for LSU Football News